J. de Jong

A monoclonal antibody-ß-glucuronidase conjugate as activator of the prodrug epirubicin-glucoronide for specific treatment of cancer (2009)

Haisma, H.J., Boven, E., Muijen, M. Van, Jong, J. De, Pinedo, H.M.

Adjectivale flexie door Nederlandssprekende kinderen met Specific Language impairment (SLI) (2008)

Schaaf, S. Van Der, Jong, J. De

In this article an exploratory study is reported on adjectival inflection in school-age children with specific language impairment (aged 6:0-7:0). Since the morphological form of the adjective is...

Bilingualism and language impairment (2008)

Jong, J. De

Magnetic field measurements and wind-line variability of OB-type stars (2008)

Schnerr, R.S., Henrichs, H.F., Neiner, C., Verdugo, E., Jong, J. De, Geers, V.C., ...

Context. The first magnetic fields in O- and B-type stars that do not belong to the Bp-star class, have been discovered. The cyclic UV wind-line variability, which has been observed in a significant...

EU research on social sciences and humanities: Psychological contracts across employment situations (2007)

Mohr, G., Rigotti, T., Schalk, R., Jong, J. De, Claes, R., Witte, H. De, ...

Histamine as a marker for hydroxyl radicals (1995)

N. M. Bhoelan, J. Blauw, J. De Jong, ...

During inflammation an influx of neutrophils and release of mediators from mast cells (such as histamine) take place. The stimulated neutrophils can produce reactive oxygen species (ROS). One of...

Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer

Ghielmini, M, Pagani, O, Jong, J De, Pampallona, S, Conti, A, Maestroni, G, ...